SYRS
Syros Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
+0.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+0.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Dec 4, 2024 | Simonian Nancy A · director | Sale | 37,070 | $0.27 |
| Nov 27, 2024 | Simonian Nancy A · director | Sale | 134,713 | $0.27 |
| Nov 20, 2024 | Stephens Kristin · officer: Chief Development Officer | Sale | 36,133 | $0.22 |
| Nov 20, 2024 | Roth David · officer: Chief Medical Officer | Sale | 12,099 | $0.20 |
| Nov 20, 2024 | Quirk Gerald E · officer: Chief Legal & Compliance Offic | Sale | 46,657 | $0.22 |
| Nov 20, 2024 | Chee Conley · director, officer: President & CEO | Sale | 134,797 | $0.20 |
| Nov 20, 2024 | Haas Jason · officer: Chief Financial Officer | Sale | 137,803 | $0.21 |
| Nov 4, 2024 | Simonian Nancy A · director | M-Exempt | 40,125 | $0.00 |
| Nov 4, 2024 | Roth David · officer: Chief Medical Officer | M-Exempt | 18,875 | $0.00 |
| Nov 4, 2024 | Roth David · officer: Chief Medical Officer | F-InKind | 6,776 | $2.09 |
| Nov 4, 2024 | Haas Jason · officer: Chief Financial Officer | M-Exempt | 18,875 | $0.00 |
| Nov 4, 2024 | Haas Jason · officer: Chief Financial Officer | F-InKind | 5,624 | $2.09 |
| Nov 4, 2024 | Chee Conley · director, officer: President & CEO | M-Exempt | 17,000 | $0.00 |
| Nov 4, 2024 | Chee Conley · director, officer: President & CEO | F-InKind | 8,707 | $2.09 |
| Nov 4, 2024 | Stephens Kristin · officer: Chief Development Officer | M-Exempt | 17,000 | $0.00 |
| Nov 4, 2024 | Stephens Kristin · officer: Chief Development Officer | F-InKind | 6,104 | $2.09 |
| Oct 2, 2024 | Quirk Gerald E · officer: Chief Legal & Compliance Offic | M-Exempt | 10,000 | $0.00 |
| Oct 2, 2024 | Quirk Gerald E · officer: Chief Legal & Compliance Offic | F-InKind | 3,100 | $2.10 |
| Sep 18, 2024 | AKKARAJU SRINIVAS · director | M-Exempt | 2,667 | $0.00 |
| Sep 18, 2024 | Young Richard A · director | M-Exempt | 2,667 | $0.00 |
| Sep 12, 2024 | Haas Jason · officer: Chief Financial Officer | Purchase | 45,344 | $1.68 |
| Sep 12, 2024 | Chee Conley · director, officer: President & CEO | Purchase | 50,000 | $1.71 |
| Sep 12, 2024 | Haas Jason · officer: Chief Financial Officer | Purchase | 19,293 | $1.58 |
| Sep 12, 2024 | Haas Jason · officer: Chief Financial Officer | Purchase | 35,363 | $1.55 |
| Jul 2, 2024 | Young Richard A · director | Sale | 34,837 | $5.12 |
| Jun 7, 2024 | Simonian Nancy A · director | A-Award | 4,000 | $0.00 |
| Jun 7, 2024 | Simonian Nancy A · director | A-Award | 6,000 | $5.30 |
| Jun 7, 2024 | Young Richard A · director | A-Award | 4,000 | $0.00 |
| Jun 7, 2024 | Young Richard A · director | A-Award | 6,000 | $5.30 |
| Jun 7, 2024 | TYSON TIMOTHY · director | A-Award | 4,000 | $0.00 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Dec 4, 2024